Previous 10 | Next 10 |
Krensavage Asset Management Opposes Sun's Lowball Bid for Taro PR Newswire NEW YORK , July 19, 2023 /PRNewswire/ -- As the largest minority shareholder 1 of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC opposes Sun Pharmace...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2023, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor Relations section of Taro...
2023-06-02 14:41:08 ET Summary Taro received a $38/share offer from Sun Pharma last month. The deal represents a decent premium to the firm's market value at the time and a 12% premium to my estimate of fair value. Further insights reveal the deal could be valuable to Taro sha...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is one of today's top gainers. The company's shares are currently up 23.11% on the day to $36.18. Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter ...
2023-05-30 13:14:47 ET Gainers: Atento ( ATTO ) +92% . Wearable Devices ( WLDS ) +86% . T2 Biosystems ( TTOO ) +55% . Arlington Asset Investment ( AAIC ) +45% . Equitrans Midstream Corporation ( ETRN ) +36% . The Glimpse Grou...
2023-05-30 12:25:31 ET Shares of Taro Pharmaceutical Industries (NYSE: TARO) were up more than 23% Tuesday morning after the company reported late Friday that in a Securities and Exchange Commission (SEC) filing, it was looking at a buyout offer from Sun Pharmaceuticals, India's lar...
2023-05-30 10:01:01 ET Gainers: HeartBeam ( BEAT ) +23% . Taro Pharmaceutical Industries ( TARO ) +22% . Akebia Therapeutics ( AKBA ) +19% . Corvus Pharmaceuticals ( CRVS ) +16% . Immix Biopharma ( IMMX ) +13% . Losers:...
2023-05-24 03:47:46 ET Taro Pharmaceutical press release ( NYSE: TARO ): Q1 GAAP EPS of $0.18 misses by $0.05 . Revenue of $146.6M misses by $4.09M . Gross profit of $75.7 million (51.6% of net sales) compared to $77.3 million (54.0% of net sales). Research...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2023. Quarter ended March 31, 2023* Highlights ─ compared to March 31, 2022 Net sales of ...
2023-05-22 17:35:17 ET Major earnings expected after the bell on Tuesday include: Agilent Technologies ( A ) Intuit ( INTU ) Palo Alto Networks ( PANW ) Toll Brothers ( TOL ) V.F. Corp. ( VFC ) For further details see: Notable earnings aft...
News, Short Squeeze, Breakout and More Instantly...
Taro Pharmaceutical Industries Ltd. Company Name:
TARO Stock Symbol:
NYSE Market:
Taro Pharmaceutical Industries Ltd. Website:
2024-06-03 08:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-24 09:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Taro Shareholders Approve Merger with Sun Pharma Canada NewsWire MUMBAI, India and NEW YORK , May 23, 2024 /CNW/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiar...